National Institute on Minority Health and Health Disparities; Notice of Closed Meeting, 13689-13690 [2013-04583]
Download as PDF
<![CDATA[
13689
Federal Register / Vol. 78, No. 40 / Thursday, February 28, 2013 / Notices
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to be
Approved for Use in NIH Funded
Research. OMB No. 0925–0601—
Expiration Date 4/30/2013—Extension—
Office of Extramural Research (OER),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,375.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dr. Ellen Gadbois,
Office of Science Policy, Office of the
Director, NIH, Building 1, Room 218,
MSC 0166, 9000 Rockville Pike,
Bethesda, MD 20892, or call non-tollfree number (301)–496–1454 or Email
your request, including your address to:
gadboisel@od.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Number of
respondents
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hour
NIH grantees and others with hESC lines .......................................................
50
3
22.5
3,375
Dated: February 21, 2013.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2013–04669 Filed 2–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Program Projects in Drug Metabolism.
Date: March 22, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
19:12 Feb 27, 2013
Jkt 229001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.18K, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Clinical Trials: Sepsis.
Date: March 25, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, Room
3An.18K, Bethesda, MD 20892, 301–594–
3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Dated: February 21, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–04579 Filed 2–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel.
Date: March 8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\28FEN1.SGM
28FEN1
13690
Federal Register / Vol. 78, No. 40 / Thursday, February 28, 2013 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–04582 Filed 2–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Dated: February 22, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–04583 Filed 2–27–13; 8:45 am]
Dated: February 22, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy .
BILLING CODE 4140–01–P
Dated: February 22, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Written Public Comments: Written public
comments may be submitted to the postal or
email address above by 5:00 p.m. ET on
Tuesday, March 12, 2013.
Accommodations Statement: Individuals
who participate by using this conference call
service and who need special assistance such
as captioning or other reasonable
accommodations should submit a request to
the Contact Person listed on this notice at
least 5 days prior to the meeting.
Schedule subject to change.
Information about the IACC and a
registration link for this meeting are available
on the Web site: www.iacc.hhs.gov.
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel AREA
Review: Cardiovascular and Respiratory
Sciences.
Date: March 21–22, 2013.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301)435–
1195, Chengy5@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2013–04580 Filed 2–27–13; 8:45 am]
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II Building, Suite 800, 6707
Democracy Boulevard, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Robert Netty, MD, Chief,
Scientific Review Officer, National Institute
On Minority Health, and Health Disparities,
6707 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, (301) 496–3996,
NETTEYR@MAIL.NIH.GOV.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Hematology.
Date: March 19, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Tobacco Control Regulatory Research.
Date: March 5, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Tomas Drgon, Ph.D.,
Scientific Review Officer, Center for
Rockville, MD 20852, Phone: (301) 443–6040,
Email: IACCPublicInquiries@mail.nih.gov.
Please Note: The conference call will be
open to the public in listen-only mode.
Members of the public who participate using
the conference call phone number will be
able to listen to the meeting but will not be
heard. If you experience any technical
problems with the conference call, pleaseemail iacchelpdesk2012@gmail.com or call
the IACC Technical Support Help Line at
301–339–3840.
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a conference call of the
Interagency Autism Coordinating
Committee (IACC).
The IACC Full Committee will have a
conference call meeting on Tuesday,
March 19, 2013. The committee will
discuss public comment, emerging
issues, and future committee activities.
The conference call will be publicly
accessible in listen-only mode.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Conference Call.
Date: March 19, 2013.
Time: 10:00 a.m. to 11:30 a.m. *Eastern
Time*—Approximate end time.
Agenda: To discuss public comment,
emerging issues, and future committee
activities.
Written Public Comments: Due by 5:00
p.m. ET on Tuesday, March 12, 2013.
Place: Conference call only; No in-person
meeting.
Conference Call: Dial: 888–790–3414;
Access code: 3436665.
Cost: The conference call is free.
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, NSC, Room 6182A,
VerDate Mar<15>2010
19:12 Feb 27, 2013
Jkt 229001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 78, Number 40 (Thursday, February 28, 2013)]
[Notices]
[Pages 13689-13690]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04583]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel.
Date: March 8, 2013.
Time: 8:00 a.m. to 5:00 p.m.
[[Page 13690]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II Building,
Suite 800, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Netty, MD, Chief, Scientific Review
Officer, National Institute On Minority Health, and Health
Disparities, 6707 Democracy Boulevard, Suite 800, Bethesda, MD
20892, (301) 496-3996, NETTEYR@MAIL.NIH.GOV.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 22, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-04583 Filed 2-27-13; 8:45 am]
BILLING CODE 4140-01-P
